{"altmetric_id":9865725,"counts":{"readers":{"mendeley":13,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["obesebrain"],"posts_count":1}},"citation":{"abstract":"Even considering the advance of the medical treatment in the last 20 years with new and more effective drugs, the outcomes are still disappointing as the control of obesity and type 2 Diabetes Mellitus (T2DM) with a large number of patients under the medical treatment still not reaching the desired outcomes.\nTo present a Metabolic Risk Score to better guide the surgical indication for T2DM patients with body mass index (BMI) where surgery for obesity is still controversial.\nResearch was conducted in PubMed, Medline, PubMed Central, Scielo and Lilacs between 2003-2015 correlating headings: metabolic surgery, obesity and type 2 diabetesmellitus. In addition, representatives of the societiesinvolved, as an expert panel, issued opinions.\nForty-five related articles were analyzed by evidence-based medicine criteria. Grouped opinions sought to answer the following questions: Why metabolic and not bariatric surgery?; Mechanisms involved in glycemic control; BMI as a single criterion for surgical indication for uncontrolled T2DM; Results of metabolic surgery studies in BMI<35 kg\/m2; Safety of metabolic surgery in patients with BMI<35 kg\/m2; Long-term effects of surgery in patients with baseline BMI<35 kg\/m2 and Proposal for a Metabolic Risk Score.\nMetabolic surgery has well-defined mechanisms of action both in experimental and human studies. Gastrointestinal interventions in T2DM patients with IMC\u226435 kg\/m2 has similar safety and efficacy when compared to groups with greater BMIs, leading to the improvement of diabetes in a superior manner than clinical treatment and lifestyle changes, in part through weight loss independent mechanisms . There is no correlation between baseline BMI and weight loss in the long term with the success rate after any surgical treatment. Gastrointestinal surgery treatment may be an option for patients with T2DM without adequate clinical control, with a BMI between 30 and 35, after thorough evaluation following the parameters detailed in Metabolic Risk Score defined by the surgical societies. Roux-en-Y gastric bypass (RYGB), because of its well known safety and efficacy and longer follow-up studies, is the main surgical technique indicated for patients eligible for surgery through the Metabolic Risk Score. The vertical sleeve gastrectomy may be considered if there is an absolute contraindication for the RYGB. T2DM patients should be evaluated by the multiprofessional team that will assess surgical eligibility, preoperative work up, follow up and long term monitoring for micro and macrovascular complications.\nMesmo considerando o avan\u00e7o do tratamento cl\u00ednico ocorrido nos \u00faltimos 20 anos, com novos e mais eficientes medicamentos, os dados ainda s\u00e3o desanimadores quanto ao controle da obesidade e da diabete melito tipo 2(DMT2),com grande parcela de doentes em tratamento cl\u00ednico ficando fora da meta desejada de controle.\nApresentar proposta de Escore de Risco Metab\u00f3lico para melhor orientar a indica\u00e7\u00e3o cir\u00fargica do diabete em pacientes com \u00edndice de massa corp\u00f3rea (IMC) mais baixo nos quais o uso de procedimento cir\u00fargico para obesidade ainda \u00e9 controverso.\nFoi realizada pesquisa nas bases de dados PubMed, Medline, PubMed Central, Scielo e Lilacs entre 2003-2015 correlacionando os descritores:cirurgia metab\u00f3lica, obesidade e diabete melito tipo 2. Adicionalmente, representantes das sociedades envolvidas emitiram opini\u00f5es em pontos nos quais n\u00e3o existia na literatura trabalhos com graus de evid\u00eancia elevados.\nForam encontrados 45 artigos relacionadosque foram analisados pelos crit\u00e9rios da medicina baseada em evid\u00eancias.As opini\u00f5es agrupadas procuraram responder as seguintes quest\u00f5es: Porque cirurgia metab\u00f3lica e n\u00e3o bari\u00e1trica?;Mecanismos envolvidos no controle glic\u00eamico; IMC como crit\u00e9rio isolado de indica\u00e7\u00e3o cir\u00fargica para o DMT2 n\u00e3o controlado; Resultados de estudos de cirurgia metab\u00f3lica em IMC<35 kg\/m2; Seguran\u00e7a da cirurgia metab\u00f3lica em pacientes com IMC<35 kg\/m2; Efeitos em longo prazo da cirurgia em pacientes com IMC inicial <35 kg\/m2; Proposta de Escore de Risco Metab\u00f3lico.\nA cirurgia metab\u00f3lica tem mecanismos de a\u00e7\u00e3o bem definidos tanto em estudos experimentais quanto em seres humanos. As interven\u00e7\u00f5es gastrointestinais em diab\u00e9ticos com IMC\u226435 kg\/m2 possuem seguran\u00e7a e efic\u00e1cia semelhantes aos grupos com IMCs maiores, levando a melhora do diabete de forma superior aos tratamentos cl\u00ednicos e mudan\u00e7as de estilo de vida, em parte atrav\u00e9s de mecanismos independentes da perda ponderal. N\u00e3o h\u00e1 correla\u00e7\u00e3o entre o IMC inicial e perda ponderal em longo prazo com os \u00edndices de sucesso do tratamento cir\u00fargico. O tratamento cir\u00fargico \u00e9 op\u00e7\u00e3o para os pacientes portadores de DMT2 sem adequado controle cl\u00ednico, com IMC entre 30 e 35, ap\u00f3s minuciosa avalia\u00e7\u00e3o seguindo os par\u00e2metros dispostos no Escore de Risco Metab\u00f3lico aqui proposto. DGYR \u00e9 a t\u00e9cnica indicada para os pacientes selecionados no Escore, existindo a possibilidade de indica\u00e7\u00e3o da gastrectomia vertical para os casos em que exista contraindica\u00e7\u00e3o para ela. O paciente deve ser avaliado por equipe multiprofissional envolvida na indica\u00e7\u00e3o, preparo e acompanhamento ap\u00f3s as opera\u00e7\u00f5es e acompanhados com monitoriza\u00e7\u00e3o de complica\u00e7\u00f5es micro e macrovasculares.","altmetric_jid":"56a768e22a83eeb12a8b4a4c","authors":["CAMPOS, Josemberg","RAMOS, Almino","SZEGO, Thomaz","ZILBERSTEIN, Bruno","FEITOSA, Hel\u00e1dio","COHEN, Ricardo","CAMPOS, Josemberg","RAMOS, Almino","SZEGO, Thomaz","ZILBERSTEIN, Bruno","FEITOSA, Hel\u00e1dio","COHEN, Ricardo"],"doi":"10.1590\/0102-67202016nahead0001","first_seen_on":"2016-07-19T21:59:00+00:00","funders":["niehs"],"issns":["2317-6326","0102-6720"],"issue":"ahead","journal":"ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)","last_mentioned_on":1468965523,"links":["http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202016005001101&lng=en&nrm=iso&tlng=en"],"pdf_url":"http:\/\/www.scielo.br\/pdf\/abcd\/2016nahead\/pt_0102-6720-abcd-2016nahead0001.pdf","pmid":"27409057","pubdate":"2016-01-01T00:00:00+00:00","publisher":"Col\u00e9gio Brasileiro de Cirurgia Digestiva - CBCD","subjects":["generalsurgery","gastroenterology"],"title":"THE ROLE OF METABOLIC SURGERY FOR PATIENTS WITH OBESITY GRADE I ANDCLINICALLY UNCONTROLLED TYPE 2 DIABETES","type":"article","volume":"0","mendeley_url":"http:\/\/www.mendeley.com\/research\/role-metabolic-surgery-patients-obesity-grade-i-andclinically-uncontrolled-type-2-diabetes-1"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":8088896,"mean":6.8703833603893,"rank":7002072,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":8088896,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":257792,"mean":11.976270024942,"rank":218065,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":257792,"percentile":1},"this_journal":{"total_number_of_other_articles":73,"mean":1.1689722222222,"rank":38,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":73,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":1,"mean":0,"rank":1,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":1,"percentile":1}}},"demographics":{"poster_types":{"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Researcher":2,"Student  > Doctoral Student":1,"Student  > Ph. D. Student":1,"Student  > Postgraduate":1,"Student  > Master":2,"Student  > Bachelor":4,"Librarian":2},"by_discipline":{"Medicine and Dentistry":11,"Nursing and Health Professions":1,"Biochemistry, Genetics and Molecular Biology":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/obesebrain\/statuses\/755522283511357440","license":"gnip","citation_ids":[9865725],"posted_on":"2016-07-19T21:58:43+00:00","author":{"name":"The Obese Brain","url":"http:\/\/theobesebrain.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/648566700661673984\/X2KGNOOv_normal.jpg","description":"Nutrition, obesity, science and your brain","id_on_source":"obesebrain","tweeter_id":"3806396543","geo":{"lt":null,"ln":null},"followers":406},"tweet_id":"755522283511357440"}]}}